全文获取类型
收费全文 | 3229篇 |
免费 | 255篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 102篇 |
妇产科学 | 74篇 |
基础医学 | 508篇 |
口腔科学 | 35篇 |
临床医学 | 354篇 |
内科学 | 703篇 |
皮肤病学 | 48篇 |
神经病学 | 315篇 |
特种医学 | 107篇 |
外科学 | 379篇 |
综合类 | 28篇 |
一般理论 | 4篇 |
预防医学 | 228篇 |
眼科学 | 79篇 |
药学 | 208篇 |
中国医学 | 12篇 |
肿瘤学 | 284篇 |
出版年
2024年 | 3篇 |
2023年 | 30篇 |
2022年 | 24篇 |
2021年 | 123篇 |
2020年 | 75篇 |
2019年 | 105篇 |
2018年 | 127篇 |
2017年 | 90篇 |
2016年 | 118篇 |
2015年 | 137篇 |
2014年 | 160篇 |
2013年 | 195篇 |
2012年 | 293篇 |
2011年 | 271篇 |
2010年 | 171篇 |
2009年 | 145篇 |
2008年 | 203篇 |
2007年 | 172篇 |
2006年 | 175篇 |
2005年 | 191篇 |
2004年 | 164篇 |
2003年 | 156篇 |
2002年 | 140篇 |
2001年 | 40篇 |
2000年 | 23篇 |
1999年 | 22篇 |
1998年 | 29篇 |
1997年 | 17篇 |
1996年 | 11篇 |
1995年 | 13篇 |
1994年 | 9篇 |
1993年 | 10篇 |
1992年 | 14篇 |
1991年 | 9篇 |
1990年 | 6篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 4篇 |
1985年 | 2篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 2篇 |
1971年 | 1篇 |
1969年 | 1篇 |
1968年 | 2篇 |
排序方式: 共有3499条查询结果,搜索用时 18 毫秒
1.
2.
AbstractThis is a secondary analysis of three qualitative studies about MAiD in which researchers asked about the differences between suicide and MAiD. In all, researchers interviewed 52 Canadians; 7 were people who had requested MAiD and had been found ineligible, 6 were MAiD providers and 39 were socially and economically marginalized. The overwhelming response was that MAiD is better than suicide in the context of suffering at the end of life. Whereas these people perceived suicide as uncertain, difficult, and something that was usually done alone and without support, they thought MAiD was certain, painless, and more socially acceptable. 相似文献
3.
4.
5.
Normal Pediatric Data for Isovolumic Acceleration at the Lateral Tricuspid Valve Annulus—A Heart Rate – Dependent Measure of Right Ventricular Contractility 下载免费PDF全文
6.
Stanislas Grassin‐Delyle Michaela Semeraro Frantz Foissac Naim Bouazza Haleema Shakur‐Still Ian Roberts Jean‐Marc Treluyer Saïk Urien 《Fundamental & clinical pharmacology》2019,33(6):670-678
Tranexamic acid (TXA) is an antifibrinolytic drug that reduces surgical blood loss and death due to bleeding after trauma and post‐partum haemorrhage. One key issue for treatment success is early administration. While usually given intravenously, oral and intramuscular use would be useful in specific circumstances. Therefore, an understanding of TXA pharmacokinetics when given via different routes is valuable. The aim of this study was to perform an individual participant data meta‐analysis of pharmacokinetic studies with TXA given to healthy volunteers via different routes. We searched the following databases: PubMed, Web of Science, Wiley Online Library, Elsevier Science Direct and J‐STAGE. Individual subject data were extracted when available, otherwise arithmetic means were used. A population pharmacokinetic model was developed using nonlinear mixed effect modelling. Seven studies were included in the analysis with data from 10 patients for the IV route, six patients for the IM route and 114 patients for the oral route. The pharmacokinetics was ascribed to a two‐compartment model, and the main covariate was allometrically scaled bodyweight. Oral and IM bioavailabilities were 46 and 105%, respectively. For a 70 kg bodyweight, the population estimates were 7.6 L/h for clearance, 17.9 L for the volume of the central compartment, 2.5 L/h for the diffusional clearance and 16.6 L for the peripheral volume of distribution. Larger well‐designed studies are needed to describe the pharmacokinetics of TXA when given IM or as an oral solution before these can be recommended as alternatives to IV. 相似文献
7.
8.
9.
10.
Michaela Roth Andreas Enström Candice Aghabeick Robert Carlsson Guillem Genové Gesine Paul 《Journal of neuroscience research》2020,98(5):826-842
Scar formation after injury of the brain or spinal cord is a common event. While glial scar formation by astrocytes has been extensively studied, much less is known about the fibrotic scar, in particular after stroke. Platelet-derived growth factor receptor ß-expressing (PDGFRß+) pericytes have been suggested as a source of the fibrotic scar depositing fibrous extracellular matrix (ECM) proteins after detaching from the vessel wall. However, to what extent these parenchymal PDGFRß+ cells contribute to the fibrotic scar and whether targeting these cells affects fibrotic scar formation in stroke is still unclear. Here, we utilize male transgenic mice that after a permanent middle cerebral artery occlusion stroke model have a shift from a parenchymal to a perivascular location of PDGFRß+ cells due to the loss of regulator of G-protein signaling 5 in pericytes. We find that only a small fraction of parenchymal PDGFRß+ cells co-label with type I collagen and fibronectin. Consequently, a reduction in parenchymal PDGFRß+ cells by ca. 50% did not affect the overall type I collagen or fibronectin deposition after stroke. The redistribution of PDGFRß+ cells to a perivascular location, however, resulted in a reduced thickening of the vascular basement membrane and changed the temporal dynamics of glial scar maturation after stroke. We demonstrate that parenchymal PDGFRß+ cells are not the main contributor to the fibrotic ECM, and therefore targeting these cells might not impact on fibrotic scar formation after stroke. 相似文献